ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 25 filers reported holding ONCOCYTE CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $375,000 | -2.1% | 150,000 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $383,000 | +21.6% | 150,000 | 0.0% | 0.01% | +100.0% |
| Q1 2018 | $315,000 | -54.9% | 150,000 | 0.0% | 0.00% | -63.6% |
| Q4 2017 | $698,000 | -38.4% | 150,000 | 0.0% | 0.01% | -45.0% |
| Q3 2017 | $1,133,000 | +45.3% | 150,000 | 0.0% | 0.02% | +42.9% |
| Q2 2017 | $780,000 | -12.7% | 150,000 | 0.0% | 0.01% | -30.0% |
| Q1 2017 | $893,000 | +97.6% | 150,000 | +134.0% | 0.02% | +100.0% |
| Q4 2016 | $452,000 | +39.9% | 64,102 | 0.0% | 0.01% | +66.7% |
| Q3 2016 | $323,000 | +41.7% | 64,102 | 0.0% | 0.01% | +20.0% |
| Q2 2016 | $228,000 | -23.0% | 64,102 | 0.0% | 0.01% | -16.7% |
| Q1 2016 | $296,000 | – | 64,102 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |